Squarepoint Ops LLC Chinook Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $61,845 - $82,542	3,532 Added 17.54%	23,670 $465,000
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $253,537 - $378,594	20,138 New	20,138 $352,000
Q1 2022 May 16, 2022	SELL	$12.02 - $16.69 $130,753 - $181,553	-10,878 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$10.69 - $16.83 $116,285 - $183,076	10,878 New	10,878 $177,000
Q2 2021 Aug 16, 2021	SELL	$13.6 - $18.98 $325,774 - $454,646	-23,954 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.17 - $19.11 $339,428 - $457,760	23,954 New	23,954 $372,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.